NYMX Insider Trading

1.14% of Nymox Pharmaceutical stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Nymox Pharmaceutical Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/27/2023	Simplicity Solutions LLC	80,000	$27K	0.0%	N/A	0.088%
5/13/2022	Warberg Asset Management LLC	24,575	$31K	0.0%	N/A	0.027%
5/12/2022	Murchinson Ltd.	76,404	$96K	0.0%	N/A	0.085%
5/11/2022	Patriot Financial Group Insurance Agency LLC	34,650	$44K	0.0%	+48.1%	0.038%
5/10/2022	MAI Capital Management	35,000	$44K	0.0%	N/A	0.039%
5/10/2022	WMS Partners LLC	42,000	$53K	0.0%	N/A	0.047%
2/10/2022	Private Advisor Group LLC	85,100	$0.11M	0.0%	-50.0%	0.101%
1/10/2022	Patriot Financial Group Insurance Agency LLC	23,400	$30K	0.0%	-25.5%	0.028%
11/24/2021	Patriot Financial Group Insurance Agency LLC	31,400	$65K	0.0%	-29.7%	0.037%
11/9/2021	BlackRock Inc.	137,668	$0.28M	0.0%	-13.8%	0.167%
11/5/2021	Advisor Group Holdings Inc.	12,100	$25K	0.0%	+365.4%	0.015%
10/14/2021	Private Advisor Group LLC	170,200	$0.35M	0.0%	+447.3%	0.207%
9/3/2021	Parametric Portfolio Associates LLC	33,665	$53K	0.0%	-49.7%	0.041%
8/17/2021	Boothbay Fund Management LLC	36,265	$57K	0.0%	N/A	0.044%
8/16/2021	State Street Corp	30,494	$48K	0.0%	-95.3%	0.037%
8/16/2021	Tibra Equities Europe Ltd	151,100	$0.24M	0.1%	N/A	0.183%
8/13/2021	Geode Capital Management LLC	41,645	$65K	0.0%	-86.3%	0.051%
8/12/2021	JPMorgan Chase & Co.	37,012	$58K	0.0%	-70.2%	0.045%
8/12/2021	Ergoteles LLC	186,210	$0.29M	0.0%	N/A	0.226%
5/19/2021	Virtu Financial LLC	12,488	$28K	0.0%	N/A	0.015%
5/18/2021	Millennium Management LLC	16,712	$37K	0.0%	N/A	0.020%
5/14/2021	Credit Suisse AG	35,751	$80K	0.0%	-14.3%	0.045%
5/13/2021	Barclays PLC	35,358	$79K	0.0%	+159.0%	0.045%
5/12/2021	Northern Trust Corp	371,944	$0.83M	0.0%	-7.2%	0.473%
5/12/2021	UBS Group AG	19,086	$42K	0.0%	+65.9%	0.024%
5/7/2021	BlackRock Inc.	1,928,450	$4.28M	0.0%	+3.4%	2.450%
3/4/2021	Geier Asset Management Inc.	35,000	$91K	0.1%	N/A	0.045%
2/19/2021	JPMorgan Chase & Co.	128,604	$0.32M	0.0%	+209.5%	0.167%
2/16/2021	Squarepoint Ops LLC	11,816	$29K	0.0%	-34.8%	0.015%
2/12/2021	Credit Suisse AG	41,721	$0.10M	0.0%	+37.1%	0.054%
2/11/2021	Barclays PLC	13,652	$34K	0.0%	-27.9%	0.018%
2/10/2021	Rhumbline Advisers	30,367	$75K	0.0%	+14.4%	0.039%
2/10/2021	Renaissance Technologies LLC	67,564	$0.17M	0.0%	+88.2%	0.088%
2/9/2021	Wells Fargo & Company MN	35,920	$90K	0.0%	+45.2%	0.047%
2/9/2021	Bank of New York Mellon Corp	101,428	$0.25M	0.0%	+12.5%	0.131%
2/5/2021	BlackRock Inc.	1,865,051	$4.63M	0.0%	-0.2%	2.416%
1/15/2021	Patriot Financial Group Insurance Agency LLC	43,250	$0.11M	0.0%	-39.7%	0.056%
12/11/2020	Virtu Financial LLC	11,659	$29K	0.0%	-58.6%	0.015%
11/17/2020	Jane Street Group LLC	43,052	$0.11M	0.0%	-48.3%	0.059%
11/16/2020	Squarepoint Ops LLC	18,115	$45K	0.0%	-70.9%	0.025%
11/16/2020	Worth Venture Partners LLC	101,999	$0.25M	0.2%	N/A	0.140%
11/12/2020	Kestra Advisory Services LLC	11,532	$28K	0.0%	N/A	0.016%
11/10/2020	State Street Corp	496,121	$1.22M	0.0%	+17.6%	0.682%

Data available starting January 2016

Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which is in various clinical trials for the treatment of benign prostatic hyperplasia and low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. The company also develops and markets NicAlert for detecting tobacco product usage; and TobacAlert for detecting second-hand smoke exposure. In addition, it develops drugs for the treatment of Alzheimer's disease. Nymox Pharmaceutical Corporation was founded in 1989 and is headquartered in Nassau, the Bahamas.